CATALYST BIOSCIENCES INC's ticker is CBIO and the CUSIP is 14888D208. A total of 53 filers reported holding CATALYST BIOSCIENCES INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $32,290 | +37.2% | 66,951 | 0.0% | 0.01% | +71.4% |
| Q2 2023 | $23,540 | +69.9% | 66,951 | 0.0% | 0.01% | +40.0% |
| Q1 2023 | $13,859 | +39497.1% | 66,951 | 0.0% | 0.01% | -50.0% |
| Q4 2022 | $35 | -99.9% | 66,951 | 0.0% | 0.01% | 0.0% |
| Q3 2022 | $34,000 | -71.4% | 66,951 | 0.0% | 0.01% | -66.7% |
| Q2 2022 | $119,000 | +170.5% | 66,951 | 0.0% | 0.03% | +275.0% |
| Q1 2022 | $44,000 | -27.9% | 66,951 | 0.0% | 0.01% | +14.3% |
| Q4 2021 | $61,000 | -77.8% | 66,951 | 0.0% | 0.01% | -70.8% |
| Q3 2021 | $275,000 | – | 66,951 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 66,951 | $13,859 | 0.01% |
| Colorado Capital Management, Inc. | 34,165 | $7 | 0.01% |
| Nantahala Capital Management | 160,430 | $33,209 | 0.00% |
| Kynam Capital Management, LP | 89,886 | $18,606 | 0.00% |
| Keebeck Wealth Management, LLC | 20,000 | $4,140 | 0.00% |
| MORGAN STANLEY | 38,404 | $7,950 | 0.00% |
| ACADIAN ASSET MANAGEMENT LLC | 259,467 | $52 | 0.00% |
| BlackRock Inc. | 169,904 | $35,170 | 0.00% |
| Bank of New York Mellon Corp | 200,638 | $41,532 | 0.00% |
| Citadel Advisors | 5,700 | $1,180 | 0.00% |